Trial intelligence / Profile preview

Testosterone Subdermal Implants in Women With Menopause

NCT06343870Phase 3Recruiting

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Dec 2025
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of testosterone in menopause, testosterone deficiency (TD), hypoestrogenism, primary ovarian insufficiency (POI), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Dec 2025; status: recruiting.

02

Drugs

testosterone
03

Conditions

menopausetestosterone deficiency (TD)hypoestrogenismprimary ovarian insufficiency (POI)

Beyond the preview

Go deeper on NCT06343870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06343870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call